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Abstract
Individual environmental factors, such as iron, temperature and oxygen, are known to have a profound effect on
bacterial phenotype. Therefore, it is surprising so little known is about the influence of chemically complex cigarette
smoke on bacterial physiology. Recent evidence has demonstrated that tobacco smoke and components alter the
bacterial surface and promote biofilm formation in several important human pathogens, including Staphylococcus
aureus, Streptococcus mutans, Klebsiella pneumonia, Porphyromonas gingivalis and Pseudomonas aeruginosa. The
mechanisms underlying this phenomenon and the relevance to increased susceptibility to infectious disease in
smokers and to treatment are reviewed.
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Introduction
The numbers of smokers and, subsequently, tobaccoinduced deaths continues to rise globally. In addition to
cancers, chronic lung disease and cardiovascular complications, cigarette use is a major risk factor for multiple
bacterial infections. These include biofilm-associated
diseases, such as community-acquired pneumonia, otitis
media, vaginosis and chronic periodontitis [1]. While
there has been considerable focus on the mechanisms by
which smoking dysregulates the immune system [2,3],
little information is available as to how smoking influences the actual bacteria that cause disease. It is clear,
however, that many bacteria exhibit a high degree of tolerance to cigarette smoke and smoke components [4-9],
while it has been known for some considerable time that
tobacco components can even promote the growth of
some pathogenic bacteria, such as Haemophilus influenzae [10]. This review summarizes the available literature
on tobacco smoke augmentation of biofilm formation by
several important human pathogens. While it is apparent
that we are only scratching the surface, mechanistically,
potential explanations for smoke-induced biofilm enhancement are discussed.
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Methods
Search strategy

Pubmed was investigated on 5 May 2014 and again on
manuscript revision according to the following search
strategies. [#1 (tobacco OR cigar* OR smok* OR nicotine) AND biofilm]; [#1 AND #2 (bacter*) AND coloniz*]; [#1 AND #2 AND membrane]; [#1 AND #2 AND
ultrastructure]; [#1 AND #2 AND LPS]; [#1 AND #2
AND fimbria*]; [#1 AND #2 AND flagella]; [#1 AND #2
AND lipoteichoic]; [#1 AND #2 AND adhesion]; [#1
AND #2 AND adhesin]; and [#1 AND #2 AND peptidoglycan]. Data identified as generated by the tobacco industry was excluded a priori.

Results and discussion
Biofilm formation and bacterial survival

Biofilms are dense, surface-attached communities of
bacteria or fungal species enclosed within a microbialderived matrix that facilitates colonization and survival.
The chemical composition, complexity and microbial diversity of a biofilm can vary relative to its environment.
However the dynamics of biofilm formation can be generalized into three interlinked stages.
Attachment of planktonic bacteria to abiotic or biotic
surfaces comprises the first stage of biofilm formation. Attachment occurs after detection of optimal nutrient or
host-derived metabolite concentrations, pH, temperature
and other favorable environmental signals [11]. Microbe-
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derived adhesive proteins and adhesive organelles, like
fimbriae and pili, facilitate attachment of planktonic bacteria to the tissue or abiotic surface. The expression profiles of genes involved in bacterial motility, extracellular
matrix formation, quorum sensing, chemotaxis and posttranscriptional regulatory circuits converge to promote
colonization and establishment of biofilms [12,13]. Significant human pathogens, including Pseudomonas aeruginosa, Vibrio cholerae and Escherichia coli, all undergo
extensive morphological and transcriptional changes to attach and colonize the host [12].
Following initial attachment, secondary species may bind
to these early colonizers, increasing biofilm complexity.
During the second stage of biofilm formation, cellular replication, synergistic intra- and inter-species interactions promote microcolony formation and the deposition of an
extracellular matrix. Microcolonies grow as a direct consequence of bacterial replication and aggregation [14]. The
extracellular matrix consists of exopolysaccharies, extracellular DNA, RNA, matrix-associated proteins and adhesins
synthesized by the colonizing bacteria which promotes cellto-cell adhesion and further stabilizes biofilm architecture.
There may be several niches or microenvironments generated within a biofilm due, for example, to nutrient, oxygen
and pH gradients. These gradients create selective pressure
and can also enhance the pathogenic potential of an
organism. The extracellular matrix also presents a diffusion barrier for most antimicrobial peptides and antimicrobial compounds.
Biofilms have been estimated to account for 65% or
more of all microbial infections in humans [15]. This
has critical implications to disease prevention as such
microbial communities provide several advantages to the
bacteria, such as (i) enhanced evolution through the
sharing of genetic material, including antibiotic resistance and other virulence factor genes; (ii) protection
from antibiotics; (iii) shielding from critical components
of the immune response, including the complement/
antibody system and phagocytosis; and (iv) the potential
to further colonize the host upon shedding from the biofilm [15-18]. Given their high degree of resistance to
current anti-microbial compounds, biofilms play a significant role in the pathogenesis of many chronic human
infections, such as cystic fibrosis, bacterial endocarditis
and periodontal diseases [19]. Furthermore, biofilms can
prolong inflammation and delay resolution in chronic
wound infections [20]. Several recent reviews of infectious biofilms are available [15,18,21-24].
Tobacco smoke promotes biofilm formation

Simple environmental stimuli, including temperature, pH
and the availability of iron, have a major influence on the
bacterial transcriptome and influence biofilm formation
in, for example, Pseudomonas aeruginosa, Klebsiella
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pneumonia, Porphyromonas gingivalis, and the melioidosis
pathogen, Burkholderia pseudomallei [25-28]. It is perhaps
not surprising, then, that cigarette smoke, which contains
thousands of chemicals, can exert a profound influence on
bacterial physiology and biofilm formation.
The evidence that tobacco promotes bacterial biofilms
in multiple pathogenic bacteria is growing, as summarized in Table 1 along with their associated diseases. The
most extensive study to date is by Goldstein-Daruech
et al. [29], who demonstrated that acute cigarette smoke
exposure significantly increased biofilm formation in
75% (12/16) of clinical isolates of various species from
smokers with chronic rhinosinusitis but in 0% (0 of 18)
of isolates from nonsmokers. Importantly, such enhanced biofilm formation was reversible on removal of
the cigarette smoke stimulus. An overall biofilm index
for smokers and non-smokers is reproduced from the
Goldstein-Daruech study in Figure 1.
Mechanisms of tobacco smoke-enhanced biofilm formation

We are only beginning to understand how tobacco
smoke may enhance microbial biofilms. However, it is
clear that the first step in biofilm formation is adherence to a stratum, be that epithelial or endothelial cells;
extant colonized bacteria; or to a sugar or protein. Tobacco smoke augments binding of Streptococcus pneumonia to pulmonary epithelial cells by inducing eukaryotic
platelet-activating factor receptor (PAF-R) expression,
which interacts with phosphorylcholine on the bacterial
cell wall [37]. In P. gingivalis, the major fimbrial protein,
FimA, is upregulated, which aids adhesion by binding to
the glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
surface protein of the primary periodontal colonizer,
Streptococcus gordonii [31]. The predominant nicotine metabolite, cotinine, has been reported to increase P. gingivalis adhesion to epithelial cell monolayers [4]. Cigarette
smoke extract (CSE) also appears to promote adhesion of
Aggregatibacter actinomycetemcomitans, an oral biofilm
dweller associated with a localized, aggressive form of
periodontal disease, to epithelial cells [38].
Sortase A (cell surface protein P1) is employed by the
cariogenic agent, Streptococcus mutans, and other Grampositive bacteria, to facilitate the localization of specific,
LPXTGX-containing proteins to the microbial surface. One
such protein is the salivary agglutinin-binding, biofilm promoting antigen I/II. It has recently been shown that the tobacco alkaloid, nicotine, upregulates the surface expression
of antigen I/II by S. mutans and, subsequently, enhances
biofilm formation [9]. The authors [9] suggest that this
nicotine-enhanced biofilm formation helps explain the increased number of teeth with carious lesions found in
smokers compared to non-smokers [39]. Indeed, nicotine
has also been shown to enhance dual species S. mutans biofilm formation with Streptococcus sanguinis [8].
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Table 1 Tobacco augments biofilm formation in multiple human pathogens
Bacterium (Gram)

Disease

Stimulus1

Study

Klebsiella pneumonia (−)

Chronic rhinosinusitis isolate

Whole smoke

Goldstein-Daruech et al. 2011 [29]

Pseudomonas aeruginosa (−)

Nosocomial infections; UTI; respiratory
infections including pneumonia

Whole smoke

Porphyromonas gingivalis (−)

Chronic periodontitis

CSE

Bagaitkar et al. 2009, 2011 [1,31]2

Proteus vulgaris (−)

Chronic rhinosinusitis isolate

Whole smoke

Goldstein-Daruech et al. 2011 [29]

Staphylococcus aureus (+)

Nosocomial infections; endocarditis; osteomyelitis;
respiratory infections

CSE

Pneumonia, bronchitis; endocarditis; meningitis

CSC

Streptococcus pneumoniae (+)

Antunes 2012 [30]
Goldstein-Daruech et al. 2011 [29]

Kulkarni 2013 [32]
Goldstein-Daruech et al. 2011 [29]
Cockeran et al. 2014 [33]
Mutepe et al. 2012 [34]
Goldstein-Daruech et al. 2011 [29]

Streptococcus mutans (+)

Dental caries

Nicotine, CSC

Li 2014 [8]3
Huang et al. 2012 [35]
Baboni 2010 [36]

1

See references for precise methods of whole smoke exposure, CSE (cigarette smoke extract) or CSC (cigarette smoke condensate) preparation and of
biofilm quantification.
Dual species biofilms with S. gordonii2 or S. sanguinis3.

Cigarette smoke exposure also leads to increased biofilm
formation in the key human pathogen, Staphylococcus
aureus, which can cause, for example, skin infections,
pneumonia, endocarditis, and septic shock [32]. The
staphylococcal genes, accessory regulator A (sarA) and
required for biofilm formation (rbf), which encode biofilm
enhancing proteins, and fibronectin binding protein A
(fnbA), whose gene product facilitates bacterial adhesion,
are upregulated by cigarette smoke. The accessory gene
regulator (agr) family of genes is involved in quorum

sensing which controls bacterial dispersal. agrC activity
is suppressed by cigarette smoke. Cigarette smokeenhanced biofilm formation in S. aureus is abrogated by
pre-treatment with the antioxidant, N-acetyl cysteine,
suggesting that smoke-induced S. aureus biofilm formation is oxidant-dependent [32].
Whole cigarette smoke exposure has been reported to
increase biofilm formation in other pathogens but, again,
there is little mechanistic insight. Several biofilm promoting P. aeruginosa genes (pilF, flgK) are induced by
cigarette smoke, while the quorum sensing gene, rhlA, is
suppressed [30]. Cigarette smoke condensate has also
been shown to increase Streptococcus pneumoniae biofilm formation associated with a reduced production of
pneumolysin, a key mediator of S. pneumoniae-induced
inflammation [34].
Tobacco smoke and oral biofilms

Figure 1 Cigarette smoke enhances the biofilm index of
multiple paranasal sinus isolates. Eighteen pathogenic bacterial
strains were isolated from non-smokers and 16 from smokers with
sinonasal mucopurulence and evaluated for biofilm forming capacity
after three hour tobacco smoke exposure from five 1R5F reference
cigarettes or sham exposure. Data from all strains was then normalized
by creating a ratio of smoke to sham exposed biofilm formation. A
value of <1 demonstrates biofilm inhibition while a value of >1 reflects
biofilm induction. The biofilm index was significantly different between
the isolates from smokers and non-smokers (p < 0.001). Data is taken
from Goldstein-Daruech et al. [29].

Presumably due to ubiquity of dental plaque, the high
prevalence of bacteria-induced oral diseases, and ease of
access to clinical samples, our knowledge of the influence of smoking on biofilms is broadest for those found
in periodontal tissues. Oral biofilms are complex and
colonize both supra- and sub-gingival regions of the oral
cavity and their composition can correlate with increased severity of periodontal disease [40].
Chronic periodontitis is a tobacco-induced and/or exacerbated disease [41]. Multiple studies have established
that smoking alters the bacterial composition of dental
plaque, with several important periodontal pathogens –
including Treponema denticola, Fusobacterium nucleatum and P. gingivalis, over-represented in cigarette
users, relative to non-smokers [1,41-45]. Commensal
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Figure 2 Cigarette smoke extract alters key P. gingivalis surface molecules and enhances biofilm formation. Representative transmission
electron microscope images of P. gingivalis grown in control medium (A) or CSE-conditioned medium (B) are shown. The black arrow indicates
the P. gingivalis capsule, which is greatly reduced in the presence of CSE. Images and data taken from Bagaitkar et al. [6]. (C, D) S. gordonii cells
(hexidium iodide-labeled, red) were placed on a saliva-coated coverglass in a flow cell. P. gingivalis cells (FITC conjugated anti-P. gingivalis IgG-labeled,
green) were passed through. P. gingivalis-S. gordonii microcolonies (yellow) were visualized by confocal microscopy. The number of dual species
microcolonies formed was significantly greater in the CSE-exposed cells compared to the controls (p < 0.01). Observation first published in [31] but data
previously unpublished in this form. (E) A model of cigarette smoke extract-induced alterations to the surface of the periodontal pathogen, P. gingivalis,
is presented. (1) Surface expression of the major fimbrial protein (FimA), but not the minor fimbrial antigen (Mfa1), is upregulated [6]. (2) At the same
time, the highly pro-inflammatory capsule is inhibited by CSE, increasing fimbrial protein bioavailability. (3) Multiple outer membrane proteins are
upregulated upon cigarette smoke exposure, including the highly antigenic RagB protein [6]. The biological significance of CSE-induced alterations to
the membrane proteome is currently under investigation. (4) While we have not examined P. gingivalis directly, the LPS profile in the saliva of smokers,
compared to that of non-smokers, exhibits altered 3-OH fatty acid content derived from overall oral microbiome [55].
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species, such as Streptococcus species may be in higher
abundance in non-smokers compared to smokers [44].
Interestingly, smokers who quit show a reversion to a
healthier biofilm composition after 6 months [46].
Increased prevalence of P. gingivalis, the laboratory
workhorse of periodontal pathogens, has been repeatedly
shown in smokers [47-50]. Furthermore, P. gingivalis is
found in significantly higher numbers in smokers than
non-smokers and infection is more persistent in smokers
compared to non-smokers [41,51]. With this in mind,
we have examined the mechanisms by which tobacco
smoke augments P. gingivalis biofilm formation. These
are summarized in Figure 2. CSE significantly influences
the expression of 6.8% of the P. gingivalis genome, as
determined by whole genome arrays, with several genes
in the P. gingivalis capsular operon significantly suppressed [6]. Transmission electron microscopy confirmed that CSE exposure suppresses capsule formation
in P. gingivalis at the ultrastructural level (Figure 2A
and B). Nicotine alone has also been reported to influence extracellular polysaccharide production in S.
mutans and S. sanguinis, partly explaining enhanced interactions between these two bacteria [8]. Furthermore,
CSE promotes P. gingivalis-Streptococcus gordonii dual
species biofilm formation [52], as shown in Figure 2C
and D. Surface expression of the major fimbrial protein
(FimA), but not the minor fimbrial antigen (Mfa1), is
upregulated by CSE [6]. This promotes interactions with
the early dental plaque colonizer, S. gordonii, enhancing
biofilm formation [31]. Indeed, FimA mutants do not form
biofilms [53]. Increased FimA production may also aid P.
gingivalis survival by suppressing the TLR-mediated inflammatory response to this pathogen [31]. As noted earlier, the highly pro-inflammatory capsule is inhibited by
CSE, which increases fimbrial protein bioavailability. Multiple outer membrane proteins are upregulated upon
cigarette smoke exposure, including the highly antigenic
RagB protein [6]. The biological significance of CSEinduced alterations to the membrane proteome is currently under investigation. P. gingivalis produces several
types of lipopolysaccharide (LPS) that comprise the external leaflet of the Gram-negative outer membrane. The inflammatory potential of these LPS isoforms is highly
variable. Penta-acylated lipid A isoforms efficiently induce
inflammation upon engagement of TLR4 on innate immune cells while tetra-acylated lipid A isoforms are antagonistic [54]. In addition to acylation, the length of lipid A
3-OH fatty acid chains also influences inflammatory capacity. While we have not examined P. gingivalis individually, lipid A-derived 3-OH fatty acid profiles in the saliva
of smokers are altered, compared to that of non-smokers,
and are consistent with an oral biofilm of reduced inflammatory potential [55]. A model of CSE-induced alterations
to P. gingivalis physiology is presented in Figure 2E.
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Conclusions
Since the discovery in 2010 that cigarette smoke extract
augments biofilm formation in the oral pathogen, P. gingivalis [52], it has become apparent that smoking promotes
bacterial adhesion and biofilm formation in several other
key pathogens, including S. mutans, S. aureus, P. aeruginosa and S. pneumoniae. Enhanced bacterial evolution, including the emergence of antibiotic resistance, protection
from antibiotics and other antimicrobials, immune response shielding and the increased potential for secondary
colonization each have clear implications to disease treatment for the present and the future. However, it is clear
that when it comes to understanding the underlying
mechanisms we are currently just “scratching the surface”.
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